Weicheng Pharmaceuticals

Suzhou, China · Founded 2025 · Privately Held (backing)

Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. Weicheng Pharmaceuticals is based in Suzhou, China and was founded in 2025. It has raised $64 million.

Last price · $/share
—
Implied valuation
—
Total raised
$64.0M
Last round
—
Team — not yet on record

No current team members for Weicheng Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.